| External validation of the Dat'AIDS score : A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older | HIV medicine | | | 2023 | 100 | 98 |
|
| Host genomics of the HIV-1 reservoir size and its decay rate during suppressive antiretroviral treatment | Journal of Acquired Immune Deficiency Syndromes | | | 2020 | 237 | 0 |
|
| Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial | PLoS medicine | | | 2020 | 233 | 264 |
|
| Emergence of drug resistance in the Swiss HIV Cohort Study under potent antiretroviral therapy is observed in socially disadvantaged patients | Clinical Infectious Diseases | | | 2020 | 378 | 3 |
|
| Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing? | Clinical Infectious Diseases | | | 2019 | 544 | 196 |
|
| On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling study | Journal of viral hepatitis | | | 2018 | 1,757 | 501 |
|
| Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study | Liver International | | | 2018 | 489 | 0 |
|
| Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens | HIV Medicine | | | 2018 | 384 | 221 |
|
| Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T-Cell Decline, and Per-Parasite Pathogenicity | Molecular Biology and Evolution | | | 2018 | 510 | 252 |
|
| Hepatitis delta-associated mortality in HIV/HBV-coinfected patients | Journal of Hepatology | | | 2017 | 437 | 609 |
|
| Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study | HIV Medicine | | | 2017 | 392 | 0 |
|
| Human papillomavirus antibody response following HAART initiation among MSM | AIDS | | | 2017 | 433 | 0 |
|
| Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study | Clinical Infectious Diseases | | | 2017 | 402 | 0 |
|
| Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030 | Swiss Medical Weekly | | | 2017 | 947 | 256 |
|
| Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study | BMC Infectious Diseases | | | 2017 | 429 | 190 |
|
| Mining for pairs: shared clinic visit dates identify steady HIV-positive partnerships | HIV Medicine | | | 2017 | 456 | 0 |
|
| Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels | Journal of Thrombosis and Haemostasis | | | 2017 | 480 | 0 |
|
| Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared | International journal of infectious diseases | | | 2016 | 517 | 212 |
|
| Contribution of Genetic Background and Clinical Risk Factors to Low-Trauma Fractures in Human Immunodeficiency Virus (HIV)-Positive Persons: The Swiss HIV Cohort Study | Open Forum Infectious Diseases | | | 2016 | 492 | 288 |
|
| Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study | The Journal of Infectious Diseases | | | 2016 | 427 | 288 |
|
| Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study | European journal of clinical investigation | | | 2015 | 619 | 0 |
|
| Generation of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests | PloS one | | | 2014 | 666 | 735 |
|
| AIDS defining opportunistic infections in patients with high CD4 counts in the combination antiretroviral therapy (cART) era: things ain't what they used to be | Journal of the International AIDS Society | | | 2014 | 642 | 314 |
|
| Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study | Open forum infectious diseases | | | 2014 | 992 | 370 |
|
| Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study | HIV medicine | | | 2013 | 656 | 0 |
|
| Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study | The Journal of infectious diseases | | | 2013 | 665 | 0 |
|
| Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection | British journal of cancer | | | 2012 | 595 | 1,112 |
|
| Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study | Journal of acquired immune deficiency syndromes | | | 2012 | 644 | 0 |
|
| Management of hepatitis C virus (HCV) infection in drug substitution programs | Schweizerische medizinische Wochenschrift | | | 2011 | 661 | 513 |
|
| Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008 | The American journal of psychiatry | | | 2010 | 696 | 0 |
|
| Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort study | AIDS research and human retroviruses | | | 2010 | 621 | 0 |
|
| High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients | AIDS | | | 2010 | 606 | 0 |
|
| Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemia | Clinical infectious diseases | | | 2010 | 623 | 0 |
|
| Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study | HIV medicine | | | 2009 | 507 | 0 |
|
| Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007 | PloS one | | | 2009 | 1,136 | 838 |
|
| 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) poisoning in Victor Yushchenko: identification and measurement of TCDD metabolites | Lancet | | | 2009 | 888 | 1 |
|
| Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy | AIDS | | | 2008 | 642 | 2 |
|
| Swiss multicenter study evaluating the efficacy, feasibility and safety of peginterferon-alfa-2a and ribavirin in patients with chronic hepatitis C in official opiate substitution programs | Digestion | | | 2008 | 590 | 2 |
|
| HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy | Clinical infectious diseases | | | 2008 | 558 | 0 |
|
| Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006 | HIV medicine | | | 2008 | 624 | 0 |
|
| Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study | Clinical infectious diseases | | | 2007 | 528 | 0 |
|
| Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission | Clinical infectious diseases | | | 2007 | 585 | 0 |
|
| Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy | Antiviral therapy | | | 2007 | 569 | 0 |
|
| Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study | Antiviral therapy | | | 2006 | 494 | 0 |
|
| Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir | AIDS | | | 2005 | 575 | 0 |
|
